<?xml version="1.0" ?>
<document id="ef4bd0f82e4290dd3d826add75846fee85ff1181">
  <chunk id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c0" text="molecules Synthesis, Characterization, and Anti-Cancer Activity of Some New N′-(2-Oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazones Derivatives">
    <entity charOffset="0-9" id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c0.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
  </chunk>
  <chunk id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c1" text="Eight novel N′-(2-oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazone derivatives 4a-h were synthesized and fully characterized by IR, NMR ( 1 H-NMR and 13 C-NMR), elemental analysis, and X-ray crystallography. The cyto-toxicity and in vitro anti-cancer evaluation of the prepared compounds have been assessed against two different human tumour cell lines including human liver (HepG2) and leukaemia (Jurkat), as well as in normal cell lines derived from human embryonic kidney (HEK293) using MTT assay. The compounds 3e, 3f, 4a, 4c, and 4e revealed promising anti-cancer activities in tested human tumour cells lines (IC50 values between 3 and 7 μM) as compared to the known anti-cancer drug 5-Fluorouracil (IC50 32-50 μM). Among the tested compounds, 4a showed specificity">
    <entity charOffset="499-502" id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c1.e0" ontology_id="CHEBI_53233" text="MTT" type="chemical"/>
    <entity charOffset="694-698" id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c1.e1" ontology_id="CHEBI_23888" text="drug" type="chemical"/>
    <entity charOffset="699-713" id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c1.e2" ontology_id="CHEBI_46345" text="5-Fluorouracil" type="chemical"/>
  </chunk>
  <chunk id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2" text="Molecules 2015, 20 14639 against leukaemia (Jurkat) cells, with an IC50 value of 3.14 μM, but this compound was inactive in liver cancer and normal cell lines.">
    <entity charOffset="0-9" id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2.e0" ontology_id="CHEBI_25367" text="Molecules" type="chemical"/>
    <entity charOffset="124-136" id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2.e1" ontology_id="DOID_3571" text="liver cancer" type="disease"/>
    <entity charOffset="130-136" id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2.e2" ontology_id="DOID_162" text="cancer" type="disease"/>
    <pair e1="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2.e0" e2="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2.e1" id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2.p0" relation="true"/>
    <pair e1="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2.e0" e2="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2.e2" id="ef4bd0f82e4290dd3d826add75846fee85ff1181.c2.p1" relation="true"/>
  </chunk>
</document>
